Relationship between plasminogen activator inhibitor type-1 (PAI-1) gene polymorphisms and osteoporosis in Turkish women.

PubWeight™: 0.76‹?›

🔗 View Article (PMC 3488989)

Published in Clinics (Sao Paulo) on November 01, 2012

Authors

Merih Ozgen1, Didem Turgut Cosan, Fulya Doganer, Ahu Soyocak, Onur Armagan, Hasan Veysi Gunes, Irfan Degirmenci, Gulsah Ogutler Ozkara, Fezan Sahin Mutlu

Author Affiliations

1: Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Eskişehir Osmangazi University, Eskisehir, Turkey.

Articles cited by this

The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med (1995) 5.27

The plasminogen activator/plasmin system. J Clin Invest (1991) 4.20

Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med (2003) 3.10

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem (1993) 1.94

Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors. Sports Med (2005) 1.60

Genetics of osteoporosis. Endocr Rev (1999) 1.56

The role of plasminogen activator inhibitor 1 in renal and cardiovascular diseases. Nat Rev Nephrol (2009) 1.38

Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res (1998) 1.37

Genetic control of susceptibility to osteoporosis. J Clin Endocrinol Metab (2002) 1.33

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb (1991) 1.30

Human genetics of osteoporosis. Best Pract Res Clin Endocrinol Metab (2008) 1.10

Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta1 gene into articular chondrocytes. J Orthop Res (2000) 1.05

The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.02

Genetics of osteoporosis. Ann N Y Acad Sci (2010) 0.95

Risk factors and prevention of osteoporosis-related fractures. J Musculoskelet Neuronal Interact (2007) 0.93

Transgenic over-expression of plasminogen activator inhibitor-1 results in age-dependent and gender-specific increases in bone strength and mineralization. Bone (2007) 0.90

The genetics of bone loss: challenges and prospects. J Clin Endocrinol Metab (2011) 0.88

Expression of TGF-β1 in the blood during fracture repair in an estrogen-deficient rat model. Clinics (Sao Paulo) (2011) 0.88

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma. Genet Test Mol Biomarkers (2009) 0.88

Genetic polymorphisms of TGF-beta, PAI-1, and COL1A-1, and determination of bone mineral density in Caucasian females. Endocr Regul (2006) 0.84

Identifying genetic risk factors for osteoporosis. J Musculoskelet Neuronal Interact (2006) 0.81

4G/5G polymorphism modulates PAI-1 circulating levels in obese women. Mol Cell Biochem (2012) 0.81

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population. Genet Test Mol Biomarkers (2010) 0.77

Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke. Genet Test (2008) 0.77

Lack of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and osteoarthritis. Rheumatol Int (2011) 0.77

Articles by these authors

Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography. Med Oncol (2008) 1.09

Double direct templating of periodically nanostructured ZnS hollow microspheres. J Am Chem Soc (2005) 0.89

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma. Genet Test Mol Biomarkers (2009) 0.88

Effect of low level laser therapy in rheumatoid arthritis patients with carpal tunnel syndrome. Swiss Med Wkly (2007) 0.88

Low power laser treatment in patients with knee osteoarthritis. Swiss Med Wkly (2004) 0.87

Sensorineural hearing loss in a patient with ankylosing spondylitis. Rheumatol Int (2004) 0.85

Are the angiotensin-converting enzyme gene and activity risk factors for stroke? Arq Neuropsiquiatr (2006) 0.84

The effects of combined application of autogenous fibroblast cell culture and full-tissue skin graft (FTSG) on wound healing and contraction in full-thickness tissue defects. Burns (2011) 0.83

The association of MMP-9 enzyme activity, MMP-9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers (2009) 0.83

Anti-inflammatuar and anti-oxidative effects of Nigella sativa L.: 18FDG-PET imaging of inflammation. Mol Biol Rep (2014) 0.83

DD genotype of ace gene I/D polymorphism is associated in a Turkish study population with osteoarthritis. Mol Biol Rep (2010) 0.83

Associated factors with urogenital score in natural and surgical menopause. Maturitas (2005) 0.82

Effects of various agents on DNA fragmentation and telomerase enzyme activities in adenocarcinoma cell lines. Mol Biol Rep (2010) 0.82

Protective effects of vitamin E on central nervous system in streptozotocin-induced diabetic rats. Clin Invest Med (2009) 0.82

Effect of Iron Therapy on Platelet Function among Iron-Deficient Women with Unexplained Menorrhagia. Pathophysiol Haemost Thromb (2009) 0.81

The hirsutism scoring system should be population specific. Fertil Steril (2005) 0.79

Impact of tannic acid on blood pressure, oxidative stress and urinary parameters in L-NNA-induced hypertensive rats. Cytotechnology (2013) 0.79

Gastroprotective, cytoprotective and antioxidant effects of Oleum cinnamomi on ethanol induced damage. Cytotechnology (2013) 0.79

The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis. Rheumatol Int (2003) 0.78

The effect of doxorubicin on rats that received toxic and carcinogenic benzo(a)pyrene. Folia Histochem Cytobiol (2008) 0.78

The effects of resveratrol and tannic acid on apoptosis in colon adenocarcinoma cell line. Saudi Med J (2009) 0.78

The protective effects of vitamin E on urinary bladder apoptosis and oxidative stress in streptozotocin-induced diabetic rats. Urology (2009) 0.77

Role of phenolic compounds in nitric oxide synthase activity in colon and breast adenocarcinoma. Cancer Biother Radiopharm (2010) 0.77

Frequency and determinants of urogenital symptoms in postmenopausal Islamic women. Menopause (2014) 0.77

Investigation of association between plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism frequency and plasma PAI-1 enzyme activity in patients with acute stroke. Genet Test (2008) 0.77

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism is associated with hypertensive patients in the Turkish population. Genet Test Mol Biomarkers (2010) 0.77

Effectiveness of physical therapy and rehabilitation programs starting immediately after lumbar disc surgery. Turk Neurosurg (2015) 0.77

The protective effects of demethoxyviridine and 1-alpha-hydroxy-demethoxyviridine in the livers of male rats treated with diethylnitrosamine and 2-acetylaminflourene. Saudi Med J (2008) 0.76

Investigation of association between Angiotensin-converting enzyme gene insertion/deletion polymorphism frequency in Turkish patients with schizophrenia. Genet Test Mol Biomarkers (2010) 0.76

The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin. Rheumatol Int (2005) 0.76

Dopamine D2 receptor gene -141C Insertion/Deletion polymorphism in Turkish schizophrenic patients. Mol Biol Rep (2010) 0.76

Antioxidant effects of melatonin and coenzyme Q10 on oxidative damage caused by single-dose ochratoxin A in rat kidney. Chin J Physiol (2010) 0.76

The association between development and progression of multinodular goiter and thyroid-stimulating hormone receptor gene D727E and P52T polymorphisms. Genet Test Mol Biomarkers (2013) 0.76

Preventive role of gallic acid on hepatic ischemia and reperfusion injury in rats. Cytotechnology (2014) 0.75

The Evaluation of Hydroxyethyl Starch (6% HES 130/0.4) Solution's Potential Preventive Effects on Coagulation Status in Women with Gynecologic Malignancies Using Rotation Thromboelastography. Turk J Haematol (2014) 0.75

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective. Genet Test Mol Biomarkers (2014) 0.75

Effects of Stevia rebaudiana (Bertoni) extract and N-nitro-L-arginine on renal function and ultrastructure of kidney cells in experimental type 2 Diabetes. J Med Food (2011) 0.75

The effect of paclitaxel on rats following benzo(a)pyrene treatment. Saudi Med J (2008) 0.75

[Drug carrier nanosystems in malignant pleural mesothelioma]. Tuberk Toraks (2016) 0.75

Effectiveness of GFAP in Determining Neuronal Damage in Rats with Induced Head Trauma. Turk Neurosurg (2016) 0.75

Angiotensin II type 1 receptor (AT1) gene A1166C is associated with the risk of hypertension. Genet Test Mol Biomarkers (2015) 0.75

High frequency of DD polymorphism of the angiotensin-converting enzyme gene in Turkish asthmatic patients. Allergy Asthma Proc (2004) 0.75

The effects of acarbose and Rumex patientia L. on ultrastructural and biochemical changes of pancreatic B cells in streptozotocin-induced diabetic rats. J Ethnopharmacol (2005) 0.75

Apoptotic effects of dipyrido [3,2-a:2',3'-c] phenazine (dppz) Au(III) complex against diethylnitrosamine/phenobarbital induced experimental hepatocarcinogenesis in rats. Mol Biol Rep (2014) 0.75